Advertisement

Topics

NicOx SA Announces That Its Exclusive Licensee Submits Response To CRL For Latanoprostene Bunod Ophthalmic Solution, 0.024%

20:00 EDT 17 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: NicOx SA Announces That Its Exclusive Licensee Submits Response To CRL For Latanoprostene Bunod Ophthalmic Solution, 0.024%

NEXT ARTICLE

More From BioPortfolio on "NicOx SA Announces That Its Exclusive Licensee Submits Response To CRL For Latanoprostene Bunod Ophthalmic Solution, 0.024%"

Advertisement
Quick Search
Advertisement
Advertisement